Adeno-associated virus vectors integrate at chromosome breakage sites
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors transduce cells by multiple pathways, including integration at nonhomologous chromosomal locations by an unknown mechanism. We reasoned that spontaneous chromosome breaks may facilitate vector integration and investigated this in cells containing a specific chromosomal double-strand break created by the endonuclease I-SceI or multiple breaks created by treatment with etoposide or gamma-irradiation. Vector proviruses were found at I-SceI cleavage sites, and sequencing of vector-chromosome junctions detected microhomologies, deletions and insertions that were similar when integration occurred spontaneously at random locations or at induced double-strand breaks. Infection with AAV vectors did not increase mutation rates in normal human cells. Our results establish a mechanism for integration and suggest that AAV vectors can integrate at existing chromosome breaks rather than causing breaks themselves, which has implications for their clinical use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Integration events can be increased by increasing dsDNA breaks in vitro by adding intron-encoded endonuclease I-SceI, etoposide, or γ-irradiation [244].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [244]
Citations
Cites
Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses
Rothkamm, K., & Löbrich, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830918100 · Cited by 1,645
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Rouet, P., Smih, F., & Jasin, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8096 · Cited by 791
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Homology-directed repair is a major double-strand break repair pathway in mammalian cells
Liang, F., Han, M., Romanienko, P. J., & Jasin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5172 · Cited by 649 · cited 1×
“, as these can also occur when DSBs undergo normal cellular repair processe”
BackgroundQuantitative Detection of125IdU-Induced DNA Double-Strand Breaks with γ-H2AX Antibody
Sedelnikova, O. A., Rogakou, E. P., Panyutin, I. G., & Bonner, W. M. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0486:qdoiid]2.0.co;2 · Cited by 611 · cited 1×
“These low values are consistent with the expected toxicity of DSBs and with earlier estimates based on staining for γ-H2A”
ResultFrequent chromosomal translocations induced by DNA double-strand breaks
Richardson, C., & Jasin, M. (2000) · Nature · doi:10.1038/35015097 · Cited by 517 · cited 1×
“, as these can also occur when DSBs undergo normal cellular repair processe”
BackgroundMechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Yee, J. K., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J. C., & Friedmann, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9564 · Cited by 487
Single-strand interruptions in replicating chromosomes cause double-strand breaks
Kuzminov, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131009198 · Cited by 406
Cited by
Items 201–266 of 266
Graves, L. E., Viswanath, L., van Dijk, E. B., Zhu, E., Koyyalamudi, S. R., Wotton, T., Rosser, S. P. A., Srinivasan, S., Ginn, S. L., & Alexander, I. E. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.011 · Cited by 4
Adeno-associated Virus as a Mammalian DNA Vector
Salganik, M., Hirsch, M. L., & Samulski, R. J. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch37 · Cited by 5
Kayesh, M. E. H., Hashem, M. A., Kohara, M., & Tsukiyama–Kohara, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.953218 · Cited by 4
Izadi, E., Mohammadi, S. S., Ganjalıkhani-Hakemi, M., Eshghi, S., Saremi, L., Saltanatpour, Z., & Hamidieh, A. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177786 · Cited by 4
RAAVioli: A comprehensive approach to characterizing AAV vector integrations and rearrangements
Cipriani, C., Rudilosso, L., Dalwadi, D. A., Masseroli, M., Grompe, M., Montini, E., Calabria, A., & Cesana, D. (2025) · Molecular Therapy Advances · doi:10.1016/j.omta.2025.201659 · Cited by 5
Hitting the Target Without Pulling the Trigger
VandenDriessche, T., & Chuah, M. (2015) · Molecular Therapy · doi:10.1038/mt.2014.230 · Cited by 3
Genome Editing for Neuromuscular Diseases
Ousterout, D. G., & Gersbach, C. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_4 · Cited by 4
Endogenous bornavirus elements in mammalian genome
Horie, M., & Tomonaga, K. (2010) · Uirusu · doi:10.2222/jsv.60.143 · Cited by 3
Safety of Adeno-Associated Viral Vectors
Lin, S., & Ertl, H. C. J. (2008) · Future Virology · doi:10.2217/17460794.3.5.491 · Cited by 3
Exploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia
Graves, L. E., Christina, S., Mullany, K., Alexander, I. E., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1719376 · Cited by 2
Jin, X., Wu, X., Song, J., Luo, M., Ye, Q., Ren, C., Li, S., Li, M., Hu, M., An, Y., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.012 · Cited by 3
Lentiviral vectors as the delivery vehicles for transduction into iPSCs
Kantor, B., & Chiba‐Falek, O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00005-x · Cited by 7
Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
Benyamini, B., Esbin, M. N., Whitney, O. N., Walther, N., & Maurer, A. C. (2023) · Journal of Visualized Experiments · doi:10.3791/65572 · Cited by 2
Libertini, S., Jadlowsky, J. K., Lanz, T. A., Mihalcik, L., & Pizzurro, D. M. (2024) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22633 · Cited by 2
Amelioration of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integrationPreprint
Chen, X., Niu, X., Liu, Y., Zheng, R., Wang, L., Yang, L., Lu, J., Yin, S., Shao, Y., Yu, W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.435908 · Cited by 2
Nonviral base editing of KCNJ13 mutation preserves vision in an inherited retinal channelopathyPreprint
Kabra, M., Shahi, P. K., Wang, Y., Sinha, D., Spillane, A., Newby, G. A., Saxena, S., Tong, Y., Chang, Y., Abdeen, A. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.12.499808 · Cited by 2
Modulation of AAV transduction and integration targeting by topoisomerase poisons
Kasimsetty, A., Hwang, Y., Everett, J. K., McFarland, A. G., Zolnoski, S. A., Lu, T., Roche, A. M., Martínez‐García, P. M., Sabatino, D. E., & Bushman, F. D. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101364 · Cited by 2
Advances in pharmacological treatment for congenital adrenal hyperplasia
Graves, L. E., & Falhammar, H. (2026) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001583 · Cited by 2
Ginn, S. L., Doroudian, F., Christina, S., Chan, O. P. Y., Lucas, C. W., Zhu, E., Yang, S. F., Devanapalli, B., Klein, A. H., Scott, S., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.06.044 · Cited by 2
Scott, S., Hallwirth, C. V., Sasaki, N., Cunningham, S. C., Zhu, E., Khandekar, N., Kizana, E., Baruteau, J., Gissen, P., Perocheau, D. P. B., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.039 · Cited by 1
Bakhshinejad, B., Javidi, M. A., Babashah, S., & Babashah, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_16 · Cited by 1
Lambert, M. S. (2008) · Applied Biosafety · doi:10.1177/153567600801300109 · Cited by 1
Random Integration Analysis of Recombinant Adeno-Associated Virus 6 Packaged in Sf9 Insect Cells
Zhang, M., Liu, X., & Zhang, C. (2023) · Molecular Biology · doi:10.1134/s0026893323040209 · Cited by 1
Random Integration Analysis of Recombinant Adeno-Associated Virus 6 Packaged in Sf9 Insect Cells
Zhang, M., Liu, X., & Zhang, C. (2023) · Molecular Biology · doi:10.31857/s0026898423040262 · Cited by 1
Gómez-Moreno, A., Sebastian, E. S., Moya, J., Gomollón-Zueco, P., Isola, S., Vales, Á., González‐Aseguinolaza, G., Unzu, C., & Garaigorta, U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102459 · Cited by 1
Jovin, I. S., & Giordano, F. J. (2007) · Wiley eBooks · doi:10.1002/9780470691977.ch9 · Cited by 1
Adeno Associated Viral Vectors for the Nervous System
Kaspar, B. K., & Gage, F. H. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-4 · Cited by 1
Targeted Gene Modification of the Nervous System
Cortés, M. L., & Breakefield, X. O. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-7 · Cited by 1
Kiourtis, C., Wilczynska, A., Nixon, C., Clark, W. A., May, S., & Bird, T. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.19.431990 · Cited by 1
Amelioration of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integrationPreprint
Li, D., Chen, X., Niu, X., Liu, Y., Zheng, R., Wang, L., Yang, L., Lu, J., Yin, S., Shao, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-302699/v1 · Cited by 1
Genome-wide assays to characterize rAAV integration into human genomic DNA in vivoPreprint
Prout, J., Stetina, J. R. V., Cerqueira, G., Chasse, M., Chen, H.-M., Pla, A., Resendes, R., Sookiasian, D., Tazearslan, C., Wright, J. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.22.554338 · Cited by 2
Jia, M. S., Padmaswari, M. H., Burcham, L. A., Agrawal, S., Bulliard, G. N., Stokes, A. L., & Nelson, C. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.01.668007 · Cited by 3
Chromosomal integration in vitro and in vivo of high capacity adenoviral vectors
Stephen, S. L. (2007) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Targeting Degradome Genes via Engineered Viral Vectors
Ala‐aho, R., Baker, A. H., & Kähäri, V. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_41
Use of Gene Transfer to Study HDL Remodeling
Oka, K., & Chan, L. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch9
Maina, C. N. (2009) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1689
Yu, C.-Y., Wang, B., Wang, Z., Cao, Z., Li, J., & Xiao, X. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.556
Immune modulation in gene therapy studies
Aerts‐Kaya, F., Kaptein, L. C. M., & Wagemaker, G. (2010) · RePub (Erasmus University Rotterdam)
Gene therapy II : viral vectors and treatment modalities
Ulm, J. W. (2005) · Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics · doi:10.1002/047001153x.g107118
Progress and challenges in gene therapy for Crigler–Najjar syndrome
Aronson, S. J., Beuers, U. H., & Bosma, P. J. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1100991 · Cited by 1
Vector-based antiviral therapy
Ensser, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_19
Novel AAV-mediated Therapeutic Strategies for Epilepsy
Foti, S. B. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wakz-r188
Bakhshinejad, B., Javidi, M. A., Babashah, S., & Babashah, S. (2014)
Novel Approaches for Pluripotent Reprogramming
Weltner, J. (2018) · Helda - University of Helsinki Institutional Repository · Cited by 1
Nicolson, S. C. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/gbv4-z740
An improved lentivirus vector for safer transgene integration and protein transduction
Schenkwein, D. (2013) · UEF eRepo (University of Eastern Finland)
Ou-Yang, H., Yang, S.-H., Chen, W., Yang, S., Cidem, A., Sung, L., & Chen, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073973
Brady, R. O. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_20
Li, W. (2023) · Blood · doi:10.1182/blood.2023019863
Understanding genetic heterogeneity in gene-edited hematopoietic stem cell products
Becker, H., & Yamazaki, S. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.11.007 · Cited by 2
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999370
Breton, C. A., Clark, P. M., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999367
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999373
Balancing Promise and Peril: Hemophilia Gene Therapy Insights
Akula, S., Borroni, E., Cottonaro, A., Follenzi, A., & Merlin, S. (2026) · IUBMB Life · doi:10.1002/iub.70087
Development of a Novel Method to Detect AAV Vector Integration
Zhang, J., Dang, T. T., Lin, T., Yu, X., Pellin, D., Tian, J., Simmons, O., Kou, E., Cornetta, K. G., & Xiao, W. (2026) · Viruses · doi:10.3390/v18030315
Li, Z., Wang, X., Liu, J., Janssen, J. M., Hoeben, R. C., & Gonçalves, M. A. F. V. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.01.006
Optimisation de la stratégie de thérapie génique par vecteur lentiviral pour la β-thalassémie
Giorgi, M. (2019) · theses.fr (ABES) · doi:10.70675/041f272dz23faz452bzb352z46cf95acb76d
Gene editing approaches of microsatellite disorders : shortening expanded repeats
Poggi, L. (2020) · theses.fr (ABES) · doi:10.70675/741f0470z28a0z4c3bz9e75ze578bdc49074 · Cited by 2
Bringing Gene Therapy Into Real World Clinical Practice
Miesbach, W., Chowdary, P., & Ozelo, M. C. (2026) · Haemophilia · doi:10.1111/hae.70229
AviTag-seq unifies nucleotide-resolution maps of CRISPR off-targets and AAV vector integrations
Li, J.-X., Zhang, S.-M., Ma, X.-Y., Deng, D.-H., Bai, P.-D., Zhao, J.-J., Gong, A., Shan-Chen, P. A. N. G., Dong, F., Wang, S.-D., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10298-6
Coratella, E., Lemmens, M., Oertli, M., Gilbart, Y., Davidsen, K., Bontadelli, L., Bohnert, R., Rigal, J., Bian, J., Alpert, T., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103050
From delivery to integration: CRISPR ‐mediated large insert gene editing in primary human T cells
Buttle, B., Verdon, D. J., & Sheppard, H. M. (2026) · Clinical & Translational Immunology · doi:10.1002/cti2.70124
Safety Risk Considerations of Cellular and Gene Therapy Products
(2026) · Elsevier eBooks · doi:10.1016/b978-0-443-48612-8.00002-6
Poller, W. C., Suckau, L., Pinkert, S., & Fechner, H. (2008) · Springer eBooks · doi:10.1007/978-3-540-78709-9_8
Metadata
- Authors
- Miller, D. G., Petek, L. M., & Russell, D. W.
- Affiliations
- University of Washington (US)
- Corresponding author
- Russell, David W
- ORCID
- Miller, Daniel G
- Venue
- Nature Genetics
- Published
- 2004-06-20
- Volume
- 36
- Issue
- 7
- Pages
- 767-773
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2050289194
- Cited by
- 266
- References
- 30
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 21 · 2022: 12 · 2021: 11 · 2020: 22 · 2019: 11 · 2018: 6 · 2017: 4 · 2016: 11 · 2015: 18 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK062100)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adeno-associated virus vectors, viral integration, chromosome breakage, DNA double-strand breaks, I-SceI endonuclease, microhomology, etoposide, gamma irradiation, provirus, mutation rate, gene therapy vectors
- MeSH terms
- Dependovirus, Base Sequence, DNA, Genetic Vectors, Humans, Molecular Sequence Data, Plasmids, Chromosome Fragile Sites, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.